Company intelligence / Profile preview

NeuroHelp

Beer-Sheva, Israel

Ownership: Private
Development stage: Other

Overview

NeuroHelp’s Epiness wearable EEG and AI platform for seizure prediction has been developed from Ben-Gurion University algorithms that achieved about 97% accuracy in offline testing on large EEG datasets, and the company reports ongoing extensive clinical trials and validation but has not yet disclosed pivotal regulatory approvals.[1][2][3][4]

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Ben-Gurion University of the Negev (BGU)[3]BGN Technologies (technology transfer company of BGU)[3]Oazis accelerator / Yazamut360 entrepreneurship center at BGU[3]

Beyond the preview

Go deeper on NeuroHelp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroHelp.

Explore the full profile